[Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D051379:Mice; D009184:Mydriatics; D009924:Organ Culture Techniques; D010276:Parasympatholytics / Q000008:administration & dosage* / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy; D010525:Peripheral Nerves / Q000187:drug effects; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects
D009184:Mydriatics; D010276:Parasympatholytics; D001285:Atropine; D012601:Scopolamine
Antimuskarinartige Wirksamkeit von Antiparkinsonmitteln as peripheren Strukturen und Korrelation zu zentraler Wirksamkeit bzw. klinischer Dosierung.